vs
AMES NATIONAL CORP（ATLO）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是AMES NATIONAL CORP的1.9倍（$35.5M vs $18.7M），AMES NATIONAL CORP净利率更高（34.9% vs -304.2%，领先339.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 26.7%），AMES NATIONAL CORP自由现金流更多（$20.7M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 19.5%）
艾姆斯国家公司是总部位于美国爱荷华州的金融控股企业，运营多家社区银行子公司，提供零售及商业银行全品类服务，涵盖存取款、个人及企业贷款、抵押贷款、财富管理等，主要服务爱荷华州中部的消费者和中小微企业。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ATLO vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.9倍
$18.7M
营收增速更快
RXRX
高出655.1%
26.7%
净利率更高
ATLO
高出339.1%
-304.2%
自由现金流更多
ATLO
多$68.0M
$-47.3M
两年增速更快
RXRX
近两年复合增速
19.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.7M | $35.5M |
| 净利润 | $6.5M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 44.3% | -304.8% |
| 净利率 | 34.9% | -304.2% |
| 营收同比 | 26.7% | 681.7% |
| 净利润同比 | 85.4% | 39.6% |
| 每股收益（稀释后） | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATLORXRX
| Q4 25 | $18.7M | $35.5M | ||
| Q3 25 | $16.6M | $5.2M | ||
| Q2 25 | $16.1M | $19.2M | ||
| Q1 25 | $15.5M | $14.7M | ||
| Q4 24 | $14.7M | $4.5M | ||
| Q3 24 | $13.5M | $26.1M | ||
| Q2 24 | $13.5M | $14.4M | ||
| Q1 24 | $13.1M | $13.8M |
净利润ATLORXRX
| Q4 25 | $6.5M | $-108.1M | ||
| Q3 25 | $4.6M | $-162.3M | ||
| Q2 25 | $4.5M | $-171.9M | ||
| Q1 25 | $3.4M | $-202.5M | ||
| Q4 24 | $3.5M | $-178.9M | ||
| Q3 24 | $2.2M | $-95.8M | ||
| Q2 24 | $2.2M | $-97.5M | ||
| Q1 24 | $2.3M | $-91.4M |
毛利率ATLORXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率ATLORXRX
| Q4 25 | 44.3% | -304.8% | ||
| Q3 25 | 34.5% | -3327.6% | ||
| Q2 25 | 35.0% | -916.8% | ||
| Q1 25 | 27.4% | -1297.9% | ||
| Q4 24 | 29.4% | -4042.4% | ||
| Q3 24 | 19.4% | -377.1% | ||
| Q2 24 | 19.0% | -697.4% | ||
| Q1 24 | 20.8% | -698.4% |
净利率ATLORXRX
| Q4 25 | 34.9% | -304.2% | ||
| Q3 25 | 27.5% | -3135.3% | ||
| Q2 25 | 28.0% | -894.2% | ||
| Q1 25 | 22.3% | -1373.3% | ||
| Q4 24 | 23.8% | -3935.5% | ||
| Q3 24 | 16.4% | -367.5% | ||
| Q2 24 | 16.2% | -676.6% | ||
| Q1 24 | 17.6% | -662.4% |
每股收益（稀释后）ATLORXRX
| Q4 25 | — | $-0.17 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $-0.41 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | — | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $126.8M | $743.3M |
| 总债务越低越好 | $18.4M | $9.6M |
| 股东权益账面价值 | $207.9M | $1.1B |
| 总资产 | $2.1B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.09× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ATLORXRX
| Q4 25 | $126.8M | $743.3M | ||
| Q3 25 | $108.2M | $659.8M | ||
| Q2 25 | $95.2M | $525.1M | ||
| Q1 25 | $163.4M | $500.5M | ||
| Q4 24 | $101.2M | $594.4M | ||
| Q3 24 | $59.0M | $427.6M | ||
| Q2 24 | $63.4M | $474.3M | ||
| Q1 24 | $111.4M | $296.3M |
总债务ATLORXRX
| Q4 25 | $18.4M | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | $20.0M | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益ATLORXRX
| Q4 25 | $207.9M | $1.1B | ||
| Q3 25 | $200.6M | $1.0B | ||
| Q2 25 | $193.0M | $919.1M | ||
| Q1 25 | $183.1M | $933.9M | ||
| Q4 24 | $174.7M | $1.0B | ||
| Q3 24 | $183.4M | $524.6M | ||
| Q2 24 | $167.1M | $584.4M | ||
| Q1 24 | $165.5M | $401.2M |
总资产ATLORXRX
| Q4 25 | $2.1B | $1.5B | ||
| Q3 25 | $2.1B | $1.4B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $2.2B | $1.3B | ||
| Q4 24 | $2.1B | $1.4B | ||
| Q3 24 | $2.1B | $726.5M | ||
| Q2 24 | $2.1B | $775.9M | ||
| Q1 24 | $2.2B | $557.8M |
负债/权益比ATLORXRX
| Q4 25 | 0.09× | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | 0.11× | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $20.7M | $-47.3M |
| 自由现金流率自由现金流/营收 | 110.8% | -133.1% |
| 资本支出强度资本支出/营收 | 3.4% | 3.5% |
| 现金转化率经营现金流/净利润 | 3.28× | — |
| 过去12个月自由现金流最近4个季度 | $34.2M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流ATLORXRX
| Q4 25 | $21.3M | $-46.1M | ||
| Q3 25 | $2.8M | $-117.4M | ||
| Q2 25 | $4.0M | $-76.4M | ||
| Q1 25 | $7.1M | $-132.0M | ||
| Q4 24 | $14.3M | $-115.4M | ||
| Q3 24 | $3.1M | $-59.2M | ||
| Q2 24 | $3.9M | $-82.2M | ||
| Q1 24 | $1.4M | $-102.3M |
自由现金流ATLORXRX
| Q4 25 | $20.7M | $-47.3M | ||
| Q3 25 | $2.6M | $-117.6M | ||
| Q2 25 | $3.9M | $-79.6M | ||
| Q1 25 | $6.9M | $-133.8M | ||
| Q4 24 | $14.0M | $-116.7M | ||
| Q3 24 | $3.0M | $-63.8M | ||
| Q2 24 | $3.8M | $-83.4M | ||
| Q1 24 | $1.3M | $-109.0M |
自由现金流率ATLORXRX
| Q4 25 | 110.8% | -133.1% | ||
| Q3 25 | 16.0% | -2272.5% | ||
| Q2 25 | 24.2% | -413.9% | ||
| Q1 25 | 44.8% | -907.4% | ||
| Q4 24 | 94.9% | -2567.7% | ||
| Q3 24 | 22.5% | -244.6% | ||
| Q2 24 | 28.1% | -578.5% | ||
| Q1 24 | 10.0% | -789.9% |
资本支出强度ATLORXRX
| Q4 25 | 3.4% | 3.5% | ||
| Q3 25 | 0.6% | 4.7% | ||
| Q2 25 | 0.7% | 16.4% | ||
| Q1 25 | 1.3% | 12.4% | ||
| Q4 24 | 2.0% | 28.6% | ||
| Q3 24 | 0.5% | 17.5% | ||
| Q2 24 | 0.7% | 8.2% | ||
| Q1 24 | 0.5% | 48.2% |
现金转化率ATLORXRX
| Q4 25 | 3.28× | — | ||
| Q3 25 | 0.60× | — | ||
| Q2 25 | 0.89× | — | ||
| Q1 25 | 2.07× | — | ||
| Q4 24 | 4.07× | — | ||
| Q3 24 | 1.40× | — | ||
| Q2 24 | 1.78× | — | ||
| Q1 24 | 0.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
